HONG KONG, Nov 19, 2024 - (ACN Newswire) - Today, Everest Medicines announced that NEFECON(R) has received full approval from the Ministry of Food and...
Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today...
Everest Medicines (1952.HK) closed today with a 20.46% increase, hitting a high of HKD 28.6. The company's stock price has been steadily rising since...